Bio-Rad names Rajat Mehta as EVP - Global Commercial Operations
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
NewCo’s pipeline includes five investigational medicines
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
3SBio will receive a payment of $1.25 billion. Pfizer will also make a $100 million equity investment in 3SBio
Reported EBITDA up by 19% year-on-year with reported EBITDA margin at 25%
Subscribe To Our Newsletter & Stay Updated